Anthrax
Inhibitors of quorum-sensing have potential in anthrax therapy
Published in Bioterrorism Week, July 4th, 2005
"Density-dependent gene expression, quorum sensing (QS), involves the synthesis and detection of low-molecular-weight molecules known as autoinducers. Inhibitors of bacterial QS systems offer potential treatment of infections with highly virulent or multidrug-resistant agents," investigators in the United States report.
"We studied the effects on Bacillus anthracis growth and the virulence gene (pagA, lef, and cya) expression of the QS inhibitor (5Z)-4-bromo-5-(bromo-methylene)3-butyl-2(5H)-furanone, which is naturally synthesized by the marine alga Delisea...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Bioterrorism Week
Source: Bioterrorism Week (2005-07-04)
More Articles from Bioterrorism Week
- Bioterrorism
Positive interim results reported from phase I clinical trial of RiVax - Drug Development
Imvamune protects monkeys against smallpox-like virus - Drug Development
Investigational anthrax antibody effective in recognized animal model - Smallpox
ACAM2000 has similar success rate, antibody response, and safety as Dryvax - Diagnostics
Biosensor system characterizes epidemic in military training camp - Myocarditis
Myocarditis following smallpox vaccination differs from ACS - More from this issue of Bioterrorism Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
